论文部分内容阅读
目的评价氨溴特罗联合阿奇霉素治疗支原体肺炎患儿的疗效。方法支原体肺炎患儿140例,分为观察组和对照组。对照组采用阿奇霉素治疗,观察组采用阿奇霉素联合氨溴特罗治疗。结果观察组总有效率为95.71%高于对照组85.71%,差异有统计学意义(P<0.05)。两组支原体肺炎患儿均未见严重不良反应事件。结论氨溴特罗联合阿奇霉素治疗支原体肺炎患儿疗效可靠。
Objective To evaluate the efficacy of combining ambroxol and azithromycin in the treatment of children with mycoplasma pneumonia. Methods 140 cases of children with mycoplasma pneumonia were divided into observation group and control group. The control group was treated with azithromycin and the observation group was treated with azithromycin and ambroxol. Results The total effective rate in observation group was 95.71%, which was significantly higher than that in control group (85.71%, P <0.05). Two groups of children with mycoplasma pneumonia were not serious adverse events. Conclusion The combination of ambroxol and azithromycin in children with mycoplasma pneumonia is reliable.